3 assets in Arteriovenous Hemangioma/Malformation

Therapeutic assets addressing Arteriovenous Hemangioma/Malformation, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lidocaine Arteriovenous Hemangioma/Malformation	The First People's Hospital of Lianyungang	P4	BB (65)
Ropivacaine Arteriovenous Hemangioma/Malformation	The First People's Hospital of Lianyungang	P4	BB (65)
Everolimus Arteriovenous Hemangioma/Malformation	Yonsei University	P2	CCC (53)